DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

H.C. Wainwright Initiates Coverage On BioNTech with Neutral Rating, Announces $30 Price Target

H.C. Wainwright analyst Robert Burns initiates coverage on BioNTech (NASDAQ:BNTX) with a Neutral rating and a $30 price target.

Benzinga · 03/09/2020 14:55

H.C. Wainwright analyst Robert Burns initiates coverage on BioNTech (NASDAQ:BNTX) with a Neutral rating and a $30 price target.